Adrian Schreiber

10PUBLICATIONS
21CO-AUTHORS
Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cardiovascular medicine and haematology not elsewhere classifiedInnate immunityHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 21, 2026
Towards a proteomic plasma biomarker panel for diagnosing vasculitis remission.

|Dec 15, 2025
CAR-T cells targeting CD19 for the treatment of ANCA vasculitis.

Dörte Lodka, Adrian Schreiber

|Mar 12, 2025
Highlights from the plenary session: cellular and molecular mechanisms of disease (I).

Jonas Zimmermann, Adrian Schreiber, Peter Heeringa

|Jan 05, 2024
CD19-targeting CAR T cells protect from ANCA-induced acute kidney injury.

Dörte Lodka, Maria Zschummel, Mario Bunse

|Jan 10, 2023
Daratumumab for the treatment of refractory ANCA-associated vasculitis.

Lennard Ostendorf, Marie Burns, Dimitrios Laurin Wagner

|Apr 14, 2022
CSF2-dependent monocyte education in the pathogenesis of ANCA-induced glomerulonephritis.

Anthony Rousselle, Janis Sonnemann, Kerstin Amann

Pageof 2

Frequent Collaborators

2 joint publications

Philipp Enghard

2 joint publications

Ralph Kettritz

1 joint publications

Udo Schneider

1 joint publications

Lennard Ostendorf